Interleukin-18 Gene Polymorphisms and Rheumatoid Arthritis Susceptibility: An Umbrella Review of Meta-Analyses

Yuehong Chen,Yali Ye,Huan Liu,Zhongling Luo,Qianwei Li,Qibing Xie

DOI: https://doi.org/10.1155/2024/6631033

IF: 4.4929

2024-02-03

Journal of Immunology Research

Abstract:This study systematically analyzes the association between interleukin-18 (IL-18) gene polymorphisms and rheumatoid arthritis (RA) susceptibility. The electronic databases Ovid MEDLINE, Ovid Excerpta Medica Database, and Cochrane Library were searched to identify meta-analyses that included case–control studies reporting IL-18 gene polymorphisms and RA susceptibility. Data were reanalyzed using Review Manager Software 5.1, and Mantel–Haenszel random effects were applied for the five genetic models: allelic, recessive, dominant, homozygote, and heterozygote. The effect size of odds ratios (ORs) and their corresponding 95% confidence interval (CI) were calculated. A total of seven meta-analyses with poor quality were included. The IL-18 polymorphisms -607 A/C, -137 C/G, -920 T/C, and -105 C/A have been reported. With weak evidence, IL-18 -607 A/C polymorphisms were associated with a reduced risk of RA susceptibility using the allele model (OR = 0.76, 95% CI: 0.61 − 0.93, p=0.01 ), dominant model (OR = 0.67, 95% CI: 0.50 − 0.90, p=0.008 ), homozygote model (OR = 0.57, 95% CI: 0.35 − 0.91, p=0.02 ), and heterozygote model (OR = 0.71, 95% CI: 0.54 − 0.93, p=0.01 ) in the overall population. IL-18 gene polymorphisms and RA susceptibility are affected by ethnicity: With weak evidence, IL-18 -137 C/G polymorphisms were related to reduce RA susceptibility in the Asian population (allele model: OR = 0.59, 95% CI: 0.40 − 0.88, p=0.01 ; dominant model: OR = 0.57, 95% CI: 0.37 − 0.89, p=0.01 ; heterozygote model: OR = 0.60, 95% CI: 0.38 − 0.94, p=0.03 ). IL-18 -607 A/C gene polymorphisms are a protective factor for RA susceptibility in the overall population, and IL-18 −137 C/G gene polymorphisms are a protective factor for RA susceptibility in the Asian population. Further studies are needed to confirm these results owing to the limitations of the included studies.

immunology